5-Amino-1MQ
NNMT inhibitor. Adipogenesis inhibition and metabolic reprogramming in adipose tissue.
COA pending
Read Index entry →
Laboratory catalogue
Cognition & Neuropeptides
Research compounds supplied with transparent specifications, public batch documentation and an uncompromising research-use-only standard.
COA required before purchase
Batch-level testing
UK dispatch
Research use only
30 products
4 compounds
Metabolic & Adipose
GLP-1 receptor agonists, mitochondrial-derived peptides, and nutrient signalling compounds. These entries cover the underlying science, mechanisms, and published research around metabolic and adipose pathways.
AOD-9604
GH fragment analogue 176-191. Lipolysis regulation without IGF-1 axis activation.
COA pending
Read Index entry →
MOTS-C
Mitochondrial-derived peptide. AMPK activation, metabolic regulation, and exercise adaptation.
COA pending
Read Index entry →
Retatrutide
Triple GLP-1/GIP/glucagon agonist. Phase II trials show significant adipose reduction.
COA pending
Read Index entry →
4 compounds
Recovery & Repair
Compounds studied for tissue regeneration, wound closure, and modulation of inflammatory pathways. Most work through extracellular matrix activity, collagen synthesis, or receptor-mediated signalling, with strong pre-clinical representation but limited published human trial data.
No. 014 Pre-clinical
RUO
BPC-157
A 15-amino-acid synthetic research peptide supplied exclusively for controlled in-vitro laboratory work. Research use only — not for human or animal...
COA pending
Read Index entry →
GHK-Cu
Glycyl-L-histidyl-L-lysine copper complex. Collagen synthesis, wound healing, and skin remodelling.
COA pending
Read Index entry →
KPV
Alpha-MSH C-terminal tripeptide. Anti-inflammatory signalling via MC1R receptor interaction.
COA pending
Read Index entry →
TB-500
Thymosin Beta-4 fragment. Studied for actin polymerisation and tissue repair signalling cascades.
COA pending
Read Index entry →
6 compounds
Vitality & Pigmentation
Compounds studied at melanocortin receptors, kisspeptin pathways, and GnRH signalling. These entries focus on receptor activity, pigmentation pathways, libido-related signalling, and hormonal research models.
Cagrilintide (CAGRI)
Long-acting amylin analogue studied in appetite suppression and metabolic regulation. Phase II data in combination with semaglutide.
COA pending
Read Index entry →
Kisspeptin
Endogenous neuropeptide acting on GPR54. Studied for GnRH pulse regulation, hormonal drive, and reproductive axis modulation.
COA pending
Read Index entry →
Melanotan I / MT-1
Linear α-MSH analogue acting on MC1R. Studied for melanogenesis, photoprotection, and UV-independent pigmentation pathways.
COA pending
Read Index entry →
Melanotan II / MT-2
Cyclic α-MSH analogue with affinity for MC1R, MC3R, and MC4R. Studied in pigmentation, libido, and appetite modulation.
COA pending
Read Index entry →
Pinealon
Tripeptide (Glu-Asp-Arg). Studied for neuroprotective effects, retinal function, and cognitive preservation in ageing models.
COA pending
Read Index entry →
PT-141 (Bremelanotide)
Cyclic heptapeptide acting on MC3R and MC4R. Studied in libido, vascular function, and sexual dysfunction models.
COA pending
Read Index entry →
4 compounds
Growth Hormone Axis
GHRH analogues, GH secretagogues, and IGF-1 modulators studied for receptor selectivity, GH pulse characteristics, and related endocrine pathways. Some compounds have clinical approval histories for specific indications, while others remain pre-clinical or early-stage.
CJC-1295
GHRH analogue with DAC modification for extended half-life. GH pulse amplification.
COA pending
Read Index entry →
Ipamorelin
Selective GH secretagogue. High selectivity; no cortisol or prolactin elevation in Phase I/II data.
COA pending
Read Index entry →
Sermorelin
GHRH 1-29 analogue. Previously FDA-approved for paediatric GH deficiency.
COA pending
Read Index entry →
Tesamorelin
FDA-approved GHRH analogue. Approved for HIV-associated lipodystrophy.
COA pending
Read Index entry →
8 compounds
Cognition & Neuropeptides
Compounds studied for neuropeptide signalling, BDNF modulation, GABAergic activity, and neuroprotection. Several entries focus on Russian and Eastern European clinical research programmes alongside pre-clinical data.
Cortagen
Tetrapeptide studied in retinal function, cortical neuroprotection, and tissue regulatory mechanisms.
COA pending
Read Index entry →
Dihexa
Hexapeptide derived from angiotensin IV. Studied for HGF/Met signalling and synaptic connectivity.
COA pending
Read Index entry →
DSIP
Delta sleep-inducing peptide. Sleep architecture, stress response, and neuroendocrine modulation.
COA pending
Read Index entry →
NAD+
Sirtuin activation, mitochondrial bioenergetics, and neurological health across Phase II studies.
COA pending
Read Index entry →
Noopept
Dipeptide GVS-111. Studied for BDNF/NGF modulation, neuroprotection, and cognitive enhancement.
COA pending
Read Index entry →
P21
CNTF-derived peptide studied for neurogenesis and BDNF-like signalling.
COA pending
Read Index entry →
Selank
Tuftsin analogue. Anxiolytic effects and memory consolidation via GABAergic modulation.
COA pending
Read Index entry →
Semax
ACTH 4-10 analogue. Studied for BDNF/NGF production, dopamine/serotonin modulation, and synaptic plasticity.
COA pending
Read Index entry →
4 compounds
Cellular Ageing
Compounds studied in the context of telomere biology, mitochondrial function, thymic signalling, cytoprotection, and epigenetic ageing biomarkers. Evidence ranges from pre-clinical cellular models to compounds with clinical or regulatory histories in specific contexts.
Epitalon
Tetrapeptide (Ala-Glu-Asp-Gly). Telomere elongation, pineal regulation, and longevity markers.
COA pending
Read Index entry →
Humanin
Mitochondria-derived peptide. Cytoprotection, IGF-1 signalling, and Alzheimer's research models.
COA pending
Read Index entry →
SS-31 (Elamipretide)
Mitochondria-targeted tetrapeptide. Phase II in heart failure and Barth syndrome. Cardiolipin binding.
COA pending
Read Index entry →
Thymosin Alpha-1
Thymic peptide approved in multiple countries for hepatitis B/C and cancer immunotherapy support.
COA pending
Read Index entry →
No catalogue products match those filters.